Total value in 2020: $120.26M

Company Partner Amount ($M) Details Date

March - $50.18M

AC Immune SA (Lausanne, Switzerland) Eli Lilly and Co. (Indianapolis) $10.18 AC Immune to receive a second milestone payment of CHF10M (US$10.18M) from Eli Lilly based on development progress in the small-molecule Morphomer tau aggregation inhibitor program 3/23/20
Cytomx Therapeutics Inc. (South San Francisco) Abbvie Inc. (North Chicago) $40.00 Cytomx Therapeutics hit a clinical milestone in its CX-2029 program triggering a $40M payment from Abbvie 3/31/20
Oxford Biotherapeutics Ltd. (Oxford, U.K.) Boehringer Ingelheim GmbH (Ingelheim, Germany) N/A Boehringer Ingelheim selected a second asset to advance into formal IND-enabling studies triggering a milestone payment to Oxford Biotherapeutics 3/31/20

No Comments